ME
Mark Elliott Boulding sold $133K of PTCT stock
Mark Elliott Boulding, Exec. VP And Clo of Ptc Therapeutics, Inc. (PTCT), sold 2,073 shares of PTCT stock worth $133K, per an SEC Form 4 filed Oct 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 5, 2026, 2 days before it was made public.
PTCT has moved -11.4% since the trade date, from $63.65 to $56.42 (Nov 20, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 7, 2026
- Filing delay
- 2 days
- Price since
- -11.4%
- Role
- Exec. VP And Clo
- Source
- SEC Form 4